FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component


48798 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Existential restriction modifier (core metadata concept)

Members targetComponentId
Aspirin 300mg soluble tablet Product containing precisely aspirin 1.5 milligram/1 milliliter conventional release oral solution (clinical drug)
Aspirin 300mg soluble tablet Product containing precisely aspirin 1.5 milligram/1 milliliter conventional release oral solution (clinical drug)
Aspirin 500mg soluble tablet (substance) Product containing precisely aspirin 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)
Aspirin 500mg soluble tablet (substance) Product containing precisely aspirin 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)
Aspirin 800mg gastro-resistant oral tablet Aspirin only product in oral dose form
Aspirin 800mg gastro-resistant oral tablet Aspirin only product in oral dose form
Aspirin 800mg m/r tablet Aspirin only product in oral dose form
Aspirin 800mg m/r tablet Aspirin only product in oral dose form
Aspirin extract Product containing aspirin (medicinal product)
Aspirin extract Product containing aspirin (medicinal product)
Aspirin+papaveretum 500mg/7.71mg dispersible tablet Product containing only aspirin and papaveretum (medicinal product)
Aspirin+papaveretum 500mg/7.71mg dispersible tablet Product containing only aspirin and papaveretum (medicinal product)
Assessment des Wissens über traditionelle Therapie Assessment of knowledge of complementary therapy (procedure)
Assessment des Wissens über traditionelle Therapie Assessment of knowledge of complementary therapy (procedure)
évaluation de l'usage de thérapies traditionnelles Assessment of use of complementary therapy (procedure)
évaluation de l'usage de thérapies traditionnelles Assessment of use of complementary therapy (procedure)
Assessment using Communication Abilities of Daily Living Second Edition Assessment using Communication Activities of Daily Living Second Edition (procedure)
Assessment using Communication Abilities of Daily Living Second Edition Assessment using Communication Activities of Daily Living Second Edition (procedure)
Assessment using World Health Organization fracture risk assessment tool for hip fracture probability Hip fracture probability assessment using FRAX (fracture risk assessment tool)
Assessment using World Health Organization fracture risk assessment tool for hip fracture probability Hip fracture probability assessment using FRAX (fracture risk assessment tool)
Assessment using World Health Organization fracture risk assessment tool for osteoporotic fracture probability Osteoporotic fracture probability assessment using osteoporotic fracture risk assessment tool (procedure)
Assessment using World Health Organization fracture risk assessment tool for osteoporotic fracture probability Osteoporotic fracture probability assessment using osteoporotic fracture risk assessment tool (procedure)
Asthma Accident and Emergency attendance since last visit Emergency asthma patient visit since last encounter (situation)
Asthma Accident and Emergency attendance since last visit Emergency asthma patient visit since last encounter (situation)
Asthma causes daytime symptoms 1 to 2 times per month Asthma causes daytime symptoms 1 to 2 times per month
Asthma causes daytime symptoms 1 to 2 times per month Asthma causes daytime symptoms 1 to 2 times per month
Asthma causes daytime symptoms 1 to 2 times per week Asthma causes daytime symptoms 1 to 2 times per week (finding)
Asthma causes daytime symptoms 1 to 2 times per week Asthma causes daytime symptoms 1 to 2 times per week (finding)
Asthma causes daytime symptoms most days Asthma causes daytime symptoms most days
Asthma causes daytime symptoms most days Asthma causes daytime symptoms most days
Asthma causes night symptoms 1 to 2 times per month Asthma causes night symptoms 1 to 2 times per month
Asthma causes night symptoms 1 to 2 times per month Asthma causes night symptoms 1 to 2 times per month
Asthma clinical management plan Asthma clinical management plan
Asthma clinical management plan Asthma clinical management plan
Asthma limits walking on the flat Asthma limits walking on the flat (finding)
Asthma limits walking on the flat Asthma limits walking on the flat (finding)
Asthma limits walking up hills or stairs Asthma limits walking up hills or stairs (finding)
Asthma never causes daytime symptoms Asthma never causes daytime symptoms (finding)
Asthma treatment compliance satisfactory Asthma treatment compliance satisfactory
Asthma treatment compliance unsatisfactory Asthma treatment compliance unsatisfactory (finding)
asthme avec état de mal asthmatique Acute severe exacerbation of asthma (disorder)
asthme avec état de mal asthmatique Acute severe exacerbation of asthma (disorder)
Astringent adverse reaction Adverse reaction caused by drug (disorder)
Astringent adverse reaction Adverse reaction caused by drug (disorder)
astrocytome Astrocytoma (morphologic abnormality)
astrocytome Astrocytoma (morphologic abnormality)
Astrovirus Astroviridae
Astrovirus Astroviridae
bactériurie asymptomatique pendant la grossesse avec complication postnatale Asymptomatic bacteriuria in pregnancy (finding)
bactériurie asymptomatique pendant la grossesse avec complication postnatale Asymptomatic bacteriuria in pregnancy (finding)
colonisation asymptomatique de la peau causée par des bactéries virulentes et/ou résistantes à un traitement Asymptomatic carrier of infectious organism on skin (finding)
colonisation asymptomatique de la peau causée par des bactéries virulentes et/ou résistantes à un traitement Asymptomatic carrier of infectious organism on skin (finding)
At increased risk due to lack of carbon monoxide detector in residence Inadequate carbon monoxide detection equipment in residence
At increased risk due to lack of carbon monoxide detector in residence Inadequate carbon monoxide detection equipment in residence
At increased risk due to lack of fire extinguisher in residence Inadequate fire extinguishing equipment in residence (finding)
At increased risk due to lack of fire extinguisher in residence Inadequate fire extinguishing equipment in residence (finding)
At increased risk due to lack of smoke detector in residence Inadequate smoke detection equipment in residence (finding)
At increased risk due to lack of smoke detector in residence Inadequate smoke detection equipment in residence (finding)
Mit Risiko einer ungeplanten Schwangerschaft At increased risk for unplanned pregnancy (finding)
Mit Risiko einer ungeplanten Schwangerschaft At increased risk for unplanned pregnancy (finding)
Ataxia co-occurrent and due to cerebrotendinous xanthomatosis Ataxia due to cerebrotendinous xanthomatosis (finding)
Ataxia co-occurrent and due to cerebrotendinous xanthomatosis Ataxia due to cerebrotendinous xanthomatosis (finding)
Ataxia due to acquired vitamin deficiency Acquired ataxia due to vitamin deficiency
Ataxia due to acquired vitamin deficiency Acquired ataxia due to vitamin deficiency
Atherosclerosis of other specified arteries Atherosclerosis
Atherosclerosis of other specified arteries Atherosclerosis
radiographie de l'atlas et de l'axis Plain X-ray of atlantoaxial joint
Atlantoaxial X-ray Plain X-ray of atlantoaxial joint
radiographie de l'atlas et de l'axis Plain X-ray of atlantoaxial joint
Atlantoaxial X-ray Plain X-ray of atlantoaxial joint
Atmospheric control NOS Respiratory therapy by atmospheric control
Atmospheric control NOS Respiratory therapy by atmospheric control
Atmospheric control NOS Respiratory therapy by atmospheric control
Atmospheric control NOS Respiratory therapy by atmospheric control
Atonic epilepsy Epilepsy
Atonic epilepsy Epilepsy
Atopic eczema/dermatitis NOS Atopic dermatitis
Atopic eczema/dermatitis NOS Atopic dermatitis
Atopic eczema/dermatitis NOS Atopic dermatitis
Atopic eczema/dermatitis NOS Atopic dermatitis
Atorvastatin calcium 10mg tablet Product containing precisely atorvastatin (as atorvastatin calcium trihydrate) 10 milligram/1 each conventional release oral tablet (clinical drug)
Atorvastatin calcium 10mg tablet Product containing precisely atorvastatin (as atorvastatin calcium) 10 milligram/1 each conventional release oral tablet (clinical drug)
Atorvastatin calcium 10mg tablet Product containing precisely atorvastatin (as atorvastatin calcium) 10 milligram/1 each conventional release oral tablet (clinical drug)
Atorvastatin calcium 20mg tablet Atorvastatin (as atorvastatin calcium) 20 mg oral tablet
Atorvastatin calcium 20mg tablet Product containing precisely atorvastatin (as atorvastatin calcium trihydrate) 20 milligram/1 each conventional release oral tablet (clinical drug)
Atorvastatin calcium 20mg tablet Atorvastatin (as atorvastatin calcium) 20 mg oral tablet
Atorvastatin calcium 40mg tablet Atorvastatin (as atorvastatin calcium) 40 mg oral tablet
Atorvastatin calcium 40mg tablet Product containing precisely atorvastatin (as atorvastatin calcium trihydrate) 40 milligram/1 each conventional release oral tablet (clinical drug)
Atorvastatin calcium 40mg tablet Atorvastatin (as atorvastatin calcium) 40 mg oral tablet
atosiban 7,5 mg/mL, fiole de 5 mL de concentré pour perfusion Product containing precisely atosiban (as atosiban acetate) 7.5 milligram/1 milliliter conventional release solution for injection (clinical drug)
atosiban 7,5 mg/mL, fiole de 5 mL de concentré pour perfusion Product containing precisely atosiban (as atosiban acetate) 7.5 milligram/1 milliliter conventional release solution for injection (clinical drug)
Atovaquone+proguanil hydrochloride Product containing atovaquone and proguanil (medicinal product)
Atovaquone+proguanil hydrochloride Product containing atovaquone and proguanil (medicinal product)
Atracurium besylate 100mg/10mL solution Product containing precisely atracurium besilate 10 milligram/1 milliliter conventional release solution for injection (clinical drug)
Atracurium besylate 100mg/10mL solution Product containing precisely atracurium besilate 10 milligram/1 milliliter conventional release solution for injection (clinical drug)
Atrial myxoma with lentigines Carney complex (disorder)
Atrial myxoma with lentigines Carney complex (disorder)
Atrioventricular block NOS Atrioventricular block
Atrioventricular block NOS Atrioventricular block
Atrioventricular block unspecified Atrioventricular block
Atrioventricular block unspecified Atrioventricular block

Start Previous Page 38 of 488 Next End


Reference Sets

Reference set descriptor

Back to Start